{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T00:21:25Z","timestamp":1794961285365,"version":"4.9.1"},"reference-count":101,"publisher":"Informa UK Limited","issue":"10","funder":[{"name":"Ceruvia Lifesciences and the Wallace Research Foundation"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Neurotherapeutics"],"published-print":{"date-parts":[[2023,10,3]]},"DOI":"10.1080\/14737175.2023.2246655","type":"journal-article","created":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T22:27:50Z","timestamp":1693520870000},"page":"867-882","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Adapting psychedelic medicine for headache and chronic pain disorders"],"prefix":"10.1080","volume":"23","author":[{"given":"Emmanuelle A. D.","family":"Schindler","sequence":"first","affiliation":[{"name":"Yale School of Medicine, Department of Neurology, New Haven, CT, USA"},{"name":"Veterans Affairs Connecticut Healthcare System, Headache Center of Excellence, West Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.","family":"Hendricks","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Neurobiology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,8,31]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000000160"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2023.109528"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.115.011478"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881108093587"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.586682"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04309-2"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1204471"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrn3516"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1152\/jn.00457.2012"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.2217\/pmt.15.27"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000001939"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2007.10.014"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy152"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-019-0757-1"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-010-0175-6"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.36076\/ppj.2011\/14\/145"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2004.04055.x"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1991.hed3108525.x"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182377dbb"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2015.1107664"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.5334\/cstp.527"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000219761.05466.43"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102417738202"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2018.10.003"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrn3057"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-017-0186-6"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-021-01224-8"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0000000000000498"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2012.02123.x"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.14021"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.14420"},{"key":"e_1_3_4_34_1","article-title":"Psilocybin-induced reduction in chronic cluster headache attack frequency correlates with changes in hypothalamic functional connectivity","author":"Madsen MK","year":"2022","unstructured":"Madsen MK, Petersen AS, Stenb\u00e6k DS, et al. Psilocybin-induced reduction in chronic cluster headache attack frequency correlates with changes in hypothalamic functional connectivity. medRxiv Preprint. 2022. https:\/\/www.medrxiv.org\/content\/10.1101\/2022.07.10.22277414v1","journal-title":"medRxiv Preprint"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102410363490"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102415583145"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102418804160"},{"key":"e_1_3_4_38_1","first-page":"116","article-title":"Prophylactic treatment of migraine by Means of lysergic acid Derivatives","volume":"6","author":"Sicuteri F","year":"1963","unstructured":"Sicuteri F. Prophylactic treatment of migraine by Means of lysergic acid Derivatives. Triangle; The Sandoz Journal Of Medical Science. 1963;6:116\u2013125.","journal-title":"Triangle; The Sandoz Journal Of Medical Science"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-020-00962-y"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32154-2"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102420905321"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1813440"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1705848"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2007.06.010"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.3988\/jcn.2021.17.3.419"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1080\/16506070600898397"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00177"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1119598109"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(71)90066-X"},{"key":"e_1_3_4_50_1","first-page":"266","article-title":"Serotonergic modulation of rat pineal gland activity: in vivo evidence for a 5-Hydroxytryptamine(2C) receptor involvement","volume":"295","author":"Steardo L","year":"2000","unstructured":"Steardo L, Monteleone P, Trabace L, et al. Serotonergic modulation of rat pineal gland activity: in vivo evidence for a 5-Hydroxytryptamine(2C) receptor involvement. J Pharmacol Exp Ther. 2000;295:266\u2013273.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.1996.1607494.x"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-020-00172-6"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01575629"},{"key":"e_1_3_4_54_1","first-page":"402P","article-title":"Alterations in sleep-wakefulness cycle in rats following treatment with (+)-lysergic acid diethylamide (LSD-25)","volume":"41","author":"Depoortere H","year":"1971","unstructured":"Depoortere H, Loew DM. Alterations in sleep-wakefulness cycle in rats following treatment with (+)-lysergic acid diethylamide (LSD-25). Br J Pharmacol. 1971;41:402P\u2013403P.","journal-title":"Br J Pharmacol"},{"key":"e_1_3_4_55_1","first-page":"354P","article-title":"Proceedings: Alterations in the sleep-wakefulness cycle in rats after administration of (-)-LSD or BOL-148: a comparison with (+)-LSD","volume":"44","author":"Depoortere H","year":"1972","unstructured":"Depoortere H, Loew DM. Proceedings: Alterations in the sleep-wakefulness cycle in rats after administration of (-)-LSD or BOL-148: a comparison with (+)-LSD. Br J Pharmacol. 1972;44:354P\u2013355P.","journal-title":"Br J Pharmacol"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00427383"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-001-0011-4"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67217-0"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.6084\/M9.FIGSHARE.1119697.V1"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2020.3285"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2022.2096"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000001384"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S315585"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2022.05.003"},{"key":"e_1_3_4_65_1","first-page":"144","article-title":"LSD-assisted psychotherapy with terminal cancer patients","volume":"9","author":"Pahnke WN","year":"1969","unstructured":"Pahnke WN, Kurland AA, Goodman LE, et al. LSD-assisted psychotherapy with terminal cancer patients. Curr Psychiatr Ther. 1969;9:144\u2013152.","journal-title":"Curr Psychiatr Ther"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.1985.10524332"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1159\/000467984"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1080\/13554794.2018.1468469"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1532-2149.2013.00433.x"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000002778"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1977.hed1703118.x"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.15987"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2022.109399"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2021.1933434"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1177\/02698811221116926"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2023.01.073"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(20)30146-2"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.05.022"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22020835"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1124\/pharmrev.121.000514"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1080\/09540261.2018.1481827"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1186\/s41038-018-0128-x"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.01069.2020"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abj9954"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1177\/02698811211055855"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2022.109127"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.10728"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1080\/09540261.2018.1474185"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.1c00014"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.788155"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030800"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2023.109426"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-022-06123-7"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2011.10.029"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-136-11-200206040-00011"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1080\/09540261.2018.1484342"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.0c00187"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2003.024240"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2020.1762023"},{"key":"e_1_3_4_100_1","unstructured":"Notice to stakeholders: health Canada\u2019s expectations regarding risk-management measures for clinical trials involving psychedelic-assisted psychotherapy. 2022."},{"key":"e_1_3_4_101_1","unstructured":"Psychedelic drugs: considerations for clinical investigations guidance for Industry (Draft guidance). United States Food and Drug Administration; 2023:https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/psychedelic-drugs-considerations-clinical-investigations."},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-196405000-00013"},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2022.109166"}],"container-title":["Expert Review of Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737175.2023.2246655","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T18:50:45Z","timestamp":1695149445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737175.2023.2246655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,31]]},"references-count":101,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10,3]]}},"alternative-id":["10.1080\/14737175.2023.2246655"],"URL":"https:\/\/doi.org\/10.1080\/14737175.2023.2246655","relation":{},"ISSN":["1473-7175","1744-8360"],"issn-type":[{"value":"1473-7175","type":"print"},{"value":"1744-8360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,31]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iern20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iern20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-04-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-31","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}